Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biora Therapeutics Inc BIOR

Healthcare Biotechnology
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for... see more

Recent & Breaking News (NDAQ:BIOR)

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 3 days ago

Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire 11 days ago

Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap(TM) Oral Delivery Platform at Digestive Disease Week 2024

GlobeNewswire 12 days ago

Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600

GlobeNewswire April 30, 2024

Biora Therapeutics Announces New Patent Covering its BioJet(TM) Liquid Jet Delivery Technology

GlobeNewswire April 8, 2024

Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap(TM) Platform Development

GlobeNewswire April 4, 2024

Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire April 3, 2024

Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire April 1, 2024

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire March 26, 2024

Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

GlobeNewswire March 18, 2024

Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

GlobeNewswire March 11, 2024

Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600

GlobeNewswire February 26, 2024

Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium

GlobeNewswire February 8, 2024

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.

GlobeNewswire January 22, 2024

Biora Therapeutics Provides Outlook for 2024

GlobeNewswire January 16, 2024

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600

GlobeNewswire January 8, 2024

Biora Therapeutics Progresses Research Collaboration for the BioJet(TM) Systemic Oral Delivery Platform

GlobeNewswire January 2, 2024

Biora Therapeutics Announces New Patent for its NaviCap(TM) Targeted Oral Delivery Platform

GlobeNewswire December 19, 2023

Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors

GlobeNewswire December 18, 2023

Biora Therapeutics Announces New Research Collaboration for the BioJet(TM) Systemic Oral Delivery Platform

GlobeNewswire December 11, 2023